M33 Growth I GP LLC
SEC CIK 1894303 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | Dir, 10% | 590.9K | — | $28.41M | 6 | 2025-05-20 | 2025-09-04 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
M33 Growth I GP LLC made no open-market trades at STLN in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-09-05 | 2025-09-04 | STLN | Starling Oncology, Inc. | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.09 | -681.8K | 590.9K | -54% | -$2.11M |
| 2025-09-05 | 2025-09-04 | STLN | Starling Oncology, Inc. | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.09 | -6.02M | 7.93M | -43% | -$18.60M | |
| 2025-06-09 | 2025-06-05 | STLN | Starling Oncology, Inc. | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.05 | -673.7K | 13.95M | -5% | -$2.05M | |
| I | 2025-06-09 | 2025-06-05 | STLN | Starling Oncology, Inc. | M33 Growth I GP LLC | Dir, 10% | S - Sale | $3.05 | -76.3K | 1.27M | -6% | -$232.8K |
| 2025-05-22 | 2025-05-20 | STLN | Starling Oncology, Inc. | M33 Growth I GP LLC | Dir, 10% | S - Sale | $2.71 | -1.80M | 14.62M | -11% | -$4.87M | |
| I | 2025-05-22 | 2025-05-20 | STLN | Starling Oncology, Inc. | M33 Growth I GP LLC | Dir, 10% | S - Sale | $2.71 | -203.5K | 1.35M | -13% | -$551.6K |
Purchase Sale Sale after option exercise All abbreviations